NCT00862992View on ClinicalTrials.gov

Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Schizophrenia
Interventions
DRUG

Cariprazine 3 mg

DRUG

Cariprazine 6 mg

DRUG

Cariprazine 12.5 mg

Trial Locations (1)

Unknown

Hoyu Hospital, Kure

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY